NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
NEOREM: Localized solid malignancies that are eligible to receive neo-adjuvant therapy and have
medical unmet needs related to disease-free survival, overall survival or quality of life / NEO-1: Resectable stage III cutaneous or mucosal melanoma amenable to intratumoral neo-adjuvant immunotherapy.
1 total trials1 recruiting
Filter these 1 trials by phase, country, sponsor and more.